Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC cancerbase no. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr . Accessed 17 Jan 2017.
2. Redaniel MT, Martin RM, Gillatt G, et al. Time from diagnosis to surgery and prostate cancer survival. BMC Cancer. 2013;13:559.
3. Poulsen MH, Dysager L, Gerke O, Lund L. Trends in prostate cancer in elderly in Denmark 1980–2012. Acta Oncol. 2016;55(Suppl 1):74–8.
4. Seikkula HA, Kaipia AJ, Rantanen ME, et al. Stage-specific mortality and survival trends in prostate cancer patients in Finland before and after introduction of PSA. Acta Oncol. 2017;56:971–7.
5. Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening. J Natl Cancer Inst. 2009;101:374–83.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献